These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 3026009

  • 1. An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections.
    Löffler L, Bauernfeind A, Keyl W, Hoffstedt B, Piergies A, Lenz W.
    Rev Infect Dis; 1986; 8 Suppl 5():S593-8. PubMed ID: 3026009
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections.
    Rev Infect Dis; 1986; 8 Suppl 5():S583-8. PubMed ID: 2879345
    [Abstract] [Full Text] [Related]

  • 7. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L, Minns P, Hageage G.
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [Abstract] [Full Text] [Related]

  • 8. Randomized comparative study of ampicillin/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children.
    Kulhanjian J, Dunphy MG, Hamstra S, Levernier K, Rankin M, Petru A, Azimi P.
    Pediatr Infect Dis J; 1989 Sep; 8(9):605-10. PubMed ID: 2677956
    [Abstract] [Full Text] [Related]

  • 9. Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections.
    Crombleholme WR, Ohm-Smith M, Robbie MO, DeKay V, Sweet RL.
    Am J Obstet Gynecol; 1987 Feb; 156(2):507-12. PubMed ID: 3030109
    [Abstract] [Full Text] [Related]

  • 10. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L, Minns P, Hageage G.
    Adv Ther; 1995 Feb; 12(1):62-71. PubMed ID: 10150322
    [Abstract] [Full Text] [Related]

  • 11. Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
    Stromberg BV, Reines HD, Hunt P.
    Surg Gynecol Obstet; 1986 Jun; 162(6):575-8. PubMed ID: 3012808
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections.
    Senft HH, Stiglmayer R, Eibach HW, Koerner H.
    Drugs; 1986 Jun; 31 Suppl 2():18-21. PubMed ID: 3013568
    [Abstract] [Full Text] [Related]

  • 15. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
    Galante D, Esposito S, Barba D, Ruffilli MP.
    J Antimicrob Chemother; 1987 Apr; 19(4):527-32. PubMed ID: 3034850
    [Abstract] [Full Text] [Related]

  • 16. A non-comparative study of parenteral ampicillin and sulbactam in intra-thoracic and intra-abdominal infections.
    Mehtar S, Croft RJ, Hilas A.
    J Antimicrob Chemother; 1986 Mar; 17(3):389-96. PubMed ID: 3009384
    [Abstract] [Full Text] [Related]

  • 17. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
    Harkless L, Boghossian J, Pollak R, Caputo W, Dana A, Gray S, Wu D.
    Surg Infect (Larchmt); 2005 Mar; 6(1):27-40. PubMed ID: 15865549
    [Abstract] [Full Text] [Related]

  • 18. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.
    Retsema JA, English AR, Girard A, Lynch JE, Anderson M, Brennan L, Cimochowski C, Faiella J, Norcia W, Sawyer P.
    Rev Infect Dis; 1986 Mar; 8 Suppl 5():S528-34. PubMed ID: 3026001
    [Abstract] [Full Text] [Related]

  • 19. Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use.
    Lees L, Milson JA, Knirsch AK, Greenhalgh K.
    Rev Infect Dis; 1986 Mar; 8 Suppl 5():S644-50. PubMed ID: 3026019
    [Abstract] [Full Text] [Related]

  • 20. Clinical, bacteriological and pharmacokinetic results from an open trial of sultamicillin in patients with acute exacerbations of chronic bronchitis.
    Davies BI, Maesen FP, van Noord JA.
    J Antimicrob Chemother; 1984 Feb; 13(2):161-70. PubMed ID: 6323377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.